MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $9,240,000 | +59.3% | 57,200 | +69.0% | 0.01% | +40.0% |
Q1 2021 | $5,799,000 | -24.4% | 33,856 | -3.1% | 0.01% | -28.6% |
Q4 2020 | $7,673,000 | +27.7% | 34,933 | -3.5% | 0.01% | +16.7% |
Q3 2020 | $6,009,000 | +45.3% | 36,191 | -0.1% | 0.01% | +33.3% |
Q2 2020 | $4,137,000 | -71.0% | 36,232 | -80.4% | 0.01% | -75.7% |
Q1 2020 | $14,243,000 | +223.4% | 185,286 | +442.2% | 0.04% | +311.1% |
Q4 2019 | $4,404,000 | -27.1% | 34,171 | -55.9% | 0.01% | -30.8% |
Q3 2019 | $6,042,000 | +4.1% | 77,557 | +37.6% | 0.01% | 0.0% |
Q2 2019 | $5,805,000 | -47.8% | 56,360 | -62.9% | 0.01% | -50.0% |
Q1 2019 | $11,128,000 | -39.9% | 151,811 | -65.2% | 0.03% | -46.9% |
Q4 2018 | $18,516,000 | +622.2% | 436,499 | +701.7% | 0.05% | +716.7% |
Q3 2018 | $2,564,000 | +13.4% | 54,448 | +18.6% | 0.01% | +100.0% |
Q2 2018 | $2,262,000 | -89.4% | 45,916 | -93.4% | 0.00% | -94.0% |
Q1 2018 | $21,293,000 | -37.9% | 693,567 | -63.1% | 0.05% | +31.6% |
Q4 2017 | $34,294,000 | – | 1,879,216 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |